Leerink Swann Upgrades Corcept Therapeutics (CORT) to Outperform; mproved Confidence in Commercial Outlook

Go back to Leerink Swann Upgrades Corcept Therapeutics (CORT) to Outperform; mproved Confidence in Commercial Outlook
Corcept Therapeutics, Inc. (NASDAQ: CORT) Delayed: 114.47 --0 (-0%)
Previous Close $114.47    52 Week High $10.00 
Open $114.47    52 Week Low $3.22 
Day High $114.47    P/E N/A 
Day Low $114.47    EPS $-0.46 
Volume 3,581